chrX-135287769-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_007131.5(ZNF75D):c.901G>A(p.Glu301Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,208,466 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 41 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_007131.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF75D | NM_007131.5 | c.901G>A | p.Glu301Lys | missense_variant | 7/7 | ENST00000370766.8 | NP_009062.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF75D | ENST00000370766.8 | c.901G>A | p.Glu301Lys | missense_variant | 7/7 | 1 | NM_007131.5 | ENSP00000359802 | P2 | |
ZNF75D | ENST00000469456.1 | n.673G>A | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
ZNF75D | ENST00000370764.1 | c.616G>A | p.Glu206Lys | missense_variant | 4/4 | 2 | ENSP00000359800 | A2 | ||
ZNF75D | ENST00000494295.1 | n.828-31992G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000205 AC: 23AN: 112458Hom.: 0 Cov.: 24 AF XY: 0.0000866 AC XY: 3AN XY: 34640
GnomAD3 exomes AF: 0.000111 AC: 20AN: 180924Hom.: 0 AF XY: 0.000152 AC XY: 10AN XY: 65680
GnomAD4 exome AF: 0.000103 AC: 113AN: 1095952Hom.: 0 Cov.: 31 AF XY: 0.000105 AC XY: 38AN XY: 361504
GnomAD4 genome AF: 0.000204 AC: 23AN: 112514Hom.: 0 Cov.: 24 AF XY: 0.0000864 AC XY: 3AN XY: 34706
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at